Additional Proxy Soliciting Materials (definitive) (defa14a)
21 9월 2022 - 5:47AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a)
of
the Securities Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant |
☒ |
|
|
Filed
by a Party other than the Registrant |
☐ |
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
|
|
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive
Proxy Statement |
|
|
☒ |
Definitive
Additional Materials |
|
|
☐ |
Soliciting
Material Pursuant to § 240.14a-12 |
INTERPACE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Its Charter)
Not
applicable
(Name
of Person(s) Filing Proxy Statement, if other than the registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No
fee required. |
|
|
☐ |
Fee
paid previously with preliminary materials. |
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Interpace Biosciences (QX) (USOTC:IDXG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Interpace Biosciences (QX) (USOTC:IDXG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Interpace Biosciences Inc (QX) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Interpace Biosciences, Inc. News Articles